Long-term cognitive and somatic outcomes of enzyme replacement therapy in untransplanted Hurler syndrome
{{output}}
Mucopolysaccharidosis type I (MPS I) was added to the Recommended Uniform Screening Panel for newborn screening in 2016, highlighting recognition that early treatment of MPS I is critical to stem progressive, irreversible disease manifestations. Enzyme replace... ...
